Validation pour Ingenuity256

vers la météo de la validation par utilisateur

Ingenuity256

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 3 - PMID ?

In liver from male SP missing a adrenal gland , intravenous administration of NODE ( with a dosage of 50 mg/kg ) is involved in expression of SP NODE mRNA 72 hours after initial treatment .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 2

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 3

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 4

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 5

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 6

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 7

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 8

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 9

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 10

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 11

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 12

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 13

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 14

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 15

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 16

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 17

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 18

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 19

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 20

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 21

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 22

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 23

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 24

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 25

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 26

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 27

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 28

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 29

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 30

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 31

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 32

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 33

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 34

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 35

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 36

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 37

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 38

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 39

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 40

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 41

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 42

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 43

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 44

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 45

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 46

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 47

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 48

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 49

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 50

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 51

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 52

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 53

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 54

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 55

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 56

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 57

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 58

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 59

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 60

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 61

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 62

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 63

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 64

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 65

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 66

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 67

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 68

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 69

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 70

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 71

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 72

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 73

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 74

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 75

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 76

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 77

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 78

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 79

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 80

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 81

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 82

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 83

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 84

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 85

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 86

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 87

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 88

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 89

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 90

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 91

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 92

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 93

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 94

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 95

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 96

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 97

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 98

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 99

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 100

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 101

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 102

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 103

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 104

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 105

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 106

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 107

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 108

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 109

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 110

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 111

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 112

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 113

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 114

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 115

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 116

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 117

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 118

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 119

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 120

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 121

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 122

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 123

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 124

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 125

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 126

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 127

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 128

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 129

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 130

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 131

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 132

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 133

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 134

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 135

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 136

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 137

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 138

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 139

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 140

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 141

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 142

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 143

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 144

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 145

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 146

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 147

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 148

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 149

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 150

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 151

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 152

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 153

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 154

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 155

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 156

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 157

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 158

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 159

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 160

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 161

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 162

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 163

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                        +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 164

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 165

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 166

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 167

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 168

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 169

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 170

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 171

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |      +-------------------------------------------SUBJ:V_PASS-N------------------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,miss)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 172

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 173

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 174

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 175

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 176

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 177

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 178

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 179

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 180

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 181

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 182

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 183

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 184

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 185

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 186

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 187

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 188

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 189

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 190

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 191

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 192

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 193

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 194

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 195

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 196

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 197

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 198

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 199

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 200

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 201

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 202

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 203

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 204

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 205

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 206

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 207

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 208

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 209

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 210

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 211

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 212

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 213

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 214

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 215

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 216

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 217

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 218

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 219

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                       +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 220

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 221

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 222

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 223

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+                                                                            
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 224

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 225

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 226

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 227

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 228

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 229

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 230

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 231

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 232

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 233

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 234

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 235

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 236

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 237

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 238

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 239

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                +-------------------------------------------COMP:V_PASS-N(from)-------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +----------------------SUBJ:V_PASS-N---------------------+            +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,__SP__)
SUBJ:V_PASS-N (involve,administration)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 240

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 241

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 242

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 243

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 244

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 245

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 246

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 247

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 248

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 249

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 250

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 251

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 252

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 253

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 254

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 255

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 256

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 257

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 258

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 259

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 260

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 261

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 262

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 263

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 264

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 265

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 266

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 267

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 268

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 269

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 270

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 271

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+-------------------------COMP:V_PASS-N(after)------------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:V_PASS-N(after) (involve,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 272

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 273

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 274

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 275

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 276

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 277

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 278

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 279

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 280

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 281

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 282

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 283

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+                                                                            
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 284

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 285

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 286

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 287

      +-----------------------------------------------------COMP:V_PASS-N(In)----------------------------------------------------+                                                                            
      |                       +----------------------------------------COMP:V_PASS-N(from)---------------------------------------+            +---------------------COMP:N-N(after)--------------------+      
      |                       |                +----------------------------------SUBJ:V_PASS-N----------------------------------+            +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+            |            |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |            +COMP:V_PASS-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |            |            |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) is involved in expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V_PASS-N(In) (involve,liver)
COMP:V_PASS-N(from) (involve,miss)
SUBJ:V_PASS-N (involve,gland)
COMP:V_PASS-N(in) (involve,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)